Adia Nutrition has appointed Dr. Richard Edwards as its second Medical Director, joining Dr. Monica Sher to form a diverse and highly experienced board. This strategic move signifies the company’s commitment to providing exceptional care and advancing innovative aHSCT treatments for patients with Multiple Sclerosis (MS).
Sanofi’s experimental drug, tolebrutinib, has shown positive results in delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis (nrSPMS). While the drug did not meet the primary endpoint in relapsing forms of MS, secondary data showed a significant delay in disability worsening. However, concerns regarding potential liver damage and effectiveness remain, impacting the drug’s revenue prospects.
A 26-year-old woman shares her journey of being diagnosed with multiple sclerosis, highlighting the importance of early detection and timely treatment. The story underscores the need to pay attention to seemingly minor symptoms and seek medical advice immediately, as early intervention can significantly impact quality of life.
Christina Applegate has revealed that she wears diapers due to a severe stomach bug she contracted from eating a tainted salad. The sapovirus infection caused intense symptoms, including dizziness, nausea, and vomiting. Despite her battle with multiple sclerosis, Applegate’s condition worsens the situation, making it challenging to reach the bathroom in time. Co-host Jamie-Lynn Sigler empathized, acknowledging that similar issues are common among those with MS.
Biogen Inc (BIIB) reported a mixed set of financial results for the first quarter of 2024. While adjusted EPS beat consensus, sales fell short of expectations. The company’s multiple sclerosis and rare disease revenues declined, but Leqembi sales accelerated, reaching approximately $19 million globally. Biogen maintained its guidance for the fiscal year 2024, with an expected EPS of $15.00-$16.00 and a low- to mid-single-digit percentage decline in total revenue. Analysts noted that the Leqembi launch faced headwinds, and the bottom-line beat was driven by cost-cutting initiatives.
Christina Applegate candidly revealed on her podcast that she contracted COVID-19, developed a chest infection due to her multiple sclerosis, and was later diagnosed with sapovirus after unknowingly consuming contaminated food. The virus caused severe gastrointestinal distress, forcing her to wear diapers. According to Applegate, she believes she contracted the sapovirus from a takeout salad, resulting in a debilitating illness that required a stool test diagnosis.
Big Brother star Kerry Riches expressed her gratitude to fans on Instagram for their support during MS Awareness Week. Having relapsing remitting multiple sclerosis, Kerry has partnered with the MS Society to raise awareness about the condition. Fans responded swiftly, securing media coverage for Kerry to share her story of living with MS. Kerry was touched by the support, acknowledging the importance of their efforts in raising awareness about the condition.
Christina Applegate, known for her role in Friends, has experienced a health setback after consuming a salad tainted with fecal matter. The infection caused severe illness, leading to incontinence and the need for diapers. Applegate previously received an Emmy for her guest appearance on Friends, and has faced challenges with Multiple Sclerosis in recent years.
Christina Applegate is opening up about her recent health struggles, including a bout of sapovirus and her ongoing battle with multiple sclerosis (MS). The actress, who is known for her roles in ‘Dead to Me’ and ‘Anchorman’, shared the details of her experience with sapovirus on the April 23 episode of her podcast, ‘MeSsy’. She described the illness as ‘pissing out of my ass for a few days’, and said it was brought on by eating takeout salad from a restaurant that was about to close down. Applegate also spoke about her MS journey, which she was diagnosed with in 2021. She said the symptoms of MS can sometimes cause difficulties in bladder control, and she has formed some strong opinions about adult diapers. Despite her health challenges, Applegate remains positive and continues to share her story with others.
Frexalimab, an anti-CD40L monoclonal antibody, demonstrated significant and sustained improvements in disease activity and low relapse rates in patients with relapsing multiple sclerosis (MS) over approximately one year of treatment. These findings, presented at the American Academy of Neurology 2024 Annual Meeting, support the potential of frexalimab as a high-efficacy therapy for relapsing MS.
